Molecular Psychiatry
(MOL PSYCHIATR) 《分子精神病学》
2015年影响因子
13.314
- 2012-12-03•咖啡引用基因组关联分析显示同 CYP1A1/CYP1A2和NRCAM的相关性
- 2012-12-03•病因学Foxp2 突变可导致畸变纹状体活性并改变技能学习的可塑性
- 2012-12-03•细胞和网络水平精神疾病建模
- 2012-12-03•精神分裂症神经发育模型:2012更新
- 2012-12-03•Rett综合症诱导多能干细胞源性神经元揭示新型神经生理改变
- 2012-12-03•血清性神经传递内源性改变测定:[11C]CUMI-101PET激发研究
- 2015-11-26•海马中细胞内腺苷A2A受体信号的光遗传学激活足以触发CREB磷酸化并损伤记忆
- 2015-11-25•阿尔兹海默病脑中P75NTR胞外域是抵抗淀粉-beta毒性的一种生理性神经保护分子
- 2015-10-29•Calcyon可刺激神经调节蛋白1成熟及发出信号
- 2015-04-29•齿状回CA3谷氨酸释放/NDMA传递介导抑郁患者的行为修复和瘦素的抗抑郁样反应
- 2014-12-15•1p13.2常见遗传突变与自闭症风险有关
- 2014-12-09•1p13.2常见遗传突变与自闭症风险有关
最新一期
IMAGE
The ADHD-linked gene Lphn3.1 controls locomotor activity and impulsivity in zebrafish
M Lange, W Norton, M Coolen, M Chaminade, S Merker, F Proft, A Schmitt, P Vernier, K-P Lesch and L Bally-Cuif
Mol Psychiatry 17: 855; doi:10.1038/mp.2012.119
Full Text | PDF
EXPERT REVIEW
The CHRNA5–A3–B4 gene cluster in nicotine addiction
W H Berrettini and G A Doyle
Mol Psychiatry 17: 856-866; advance online publication, October 4, 2011; doi:10.1038/mp.2011.122
Abstract | Full Text | PDF
IMMEDIATE COMMUNICATIONS
Visual analysis of geocoded twin data puts nature and nurture on the map Open
O S P Davis, C M A Haworth, C M Lewis and R Plomin
Mol Psychiatry 17: 867-874; advance online publication, June 12, 2012; doi:10.1038/mp.2012.68
Abstract | Full Text | PDF | Supplementary information
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease
C Pottier, D Hannequin, S Coutant, A Rovelet-Lecrux, D Wallon, S Rousseau, S Legallic, C Paquet, S Bombois, J Pariente, C Thomas-Anterion, A Michon, B Croisile, F Etcharry-Bouyx, C Berr, J-F Dartigues, P Amouyel, H Dauchel, C Boutoleau-Bretonnière, C Thauvin, T Frebourg, J-C Lambert and D Campion PHRC GMAJ Collaborators
Mol Psychiatry 17: 875-879; advance online publication, April 3, 2012; doi:10.1038/mp.2012.15
Abstract | Full Text | PDF | Supplementary information
Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder
S E Bergen, C T O'Dushlaine, S Ripke, P H Lee, D M Ruderfer, S Akterin, J L Moran, K D Chambert, R E Handsaker, L Backlund, U Ösby, S McCarroll, M Landen, E M Scolnick, P K E Magnusson, P Lichtenstein, C M Hultman, S M Purcell, P Sklar and P F Sullivan
Mol Psychiatry 17: 880-886; advance online publication, June 12, 2012; doi:10.1038/mp.2012.73
Abstract | Full Text | PDF | Supplementary information
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction Open
M Ayalew, H Le-Niculescu, D F Levey, N Jain, B Changala, S D Patel, E Winiger, A Breier, A Shekhar, R Amdur, D Koller, J I Nurnberger, A Corvin, M Geyer, M T Tsuang, D Salomon, N J Schork, A H Fanous, M C O'Donovan and A B Niculescu
Mol Psychiatry 17: 887-905; advance online publication, May 15, 2012; doi:10.1038/mp.2012.37
Abstract | Full Text | PDF | Supplementary information
ORIGINAL ARTICLES
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe
M Rietschel, M Mattheisen, F Degenhardt, GROUP Investigators, T W Mühleisen, P Kirsch, C Esslinger, S Herms, D Demontis, M Steffens, J Strohmaier, B Haenisch, R Breuer, P M Czerski, I Giegling, E Strengman, C Schmael, O Mors, P B Mortensen, D M Hougaard, T Ørntoft, P Kapelski, L Priebe, F B Basmanav, A J Forstner, P Hoffmann, S Meier, J Nikitopoulos, S Moebus, M Alexander, R Mössner, H-E Wichmann, S Schreiber, F Rivandeneira, A Hofman, A G Uitterlinden, T F Wienker, J Schumacher, J Hauser, W Maier, R M Cantor, S Erk, T G Schulze, SGENE-plus Consortium, N Craddock, M J Owen, M C O'Donovan, A D Børglum, D Rujescu, H Walter, A Meyer-Lindenberg, M M Nöthen, R A Ophoff and S Cichon
Mol Psychiatry 17: 906-917; advance online publication, July 12, 2011; doi:10.1038/mp.2011.80
Abstract | Full Text | PDF | Supplementary information
Decreased dopamine activity predicts relapse in methamphetamine abusers
G J Wang, L Smith, N D Volkow, F Telang, J Logan, D Tomasi, C T Wong, W Hoffman, M Jayne, N Alia-Klein, P Thanos and J S Fowler
Mol Psychiatry 17: 918-925; advance online publication, July 12, 2011; doi:10.1038/mp.2011.86
Abstract | Full Text | PDF
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response
A Bacq, L Balasse, G Biala, B Guiard, A M Gardier, A Schinkel, F Louis, V Vialou, M-P Martres, C Chevarin, M Hamon, B Giros and S Gautron
Mol Psychiatry 17: 926-939; advance online publication, July 19, 2011; doi:10.1038/mp.2011.87
Abstract | Full Text | PDF | Supplementary information
Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing
M Hamer, G D Batty and M Kivimaki
Mol Psychiatry 17: 940-945; advance online publication, April 24, 2012; doi:10.1038/mp.2012.30
Abstract | Full Text | PDF | Supplementary information
The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development
M Lange, W Norton, M Coolen, M Chaminade, S Merker, F Proft, A Schmitt, P Vernier, K-P Lesch and L Bally-Cuif
Mol Psychiatry 17: 946-954; advance online publication, April 17, 2012; doi:10.1038/mp.2012.29
Abstract | Full Text | PDF | Supplementary information